Kerri Fitzgerald

Kerri Fitzgerald is a medical writer and editor who has written for AAOS Now, ASH Clinical News, ONS Voice, JMCP, and CHEST Journal.

Articles by Kerri Fitzgerald

Kerri FitzgeraldBlood Cancers | February 27, 2023
Racial and ethnic outcomes disparities persist for B-cell ALL; however, a study did not observe the same trend for T-cell ALL
Read More
Kerri FitzgeraldBlood Cancers | February 27, 2023
A study observed significant demographic and geographic disparities among leukemia and myeloma patients
Kerri FitzgeraldMultiple Myeloma | February 27, 2023
Multiple myeloma (MM) is a rare and heterogeneous blood cancer of the plasma cells. Although therapies have been ...
Kerri FitzgeraldMultiple Myeloma | February 27, 2023
Iberdomide, an oral potent novel cereblon E3 ligase modulator (CELMoD), in combination with other agents demonstrated an ...
Kerri FitzgeraldMultiple Myeloma | February 27, 2023
A study presented at the ASH Annual Meeting & Exposition found that among six landmark multiple myeloma (MM) ...
Kerri FitzgeraldMultiple Myeloma | February 27, 2023
cilta-cel is a structurally distinct second-generation chimeric antigen receptor therapy with two BCMA-binding domains.
Kerri FitzgeraldMultiple Myeloma | February 27, 2023
Ajai Chari, MD, PhD, of Mount Sinai Medical Center discusses findings from a phase I study of the novel agent, talquetamab.
Kerri FitzgeraldMultiple Myeloma | February 27, 2023
Enrollment in the phase I dose escalation portion is ongoing, and the phase II portion of the study is recruiting.
Kerri FitzgeraldMultiple Myeloma | February 27, 2023
A study published in the Journal of Geriatric Oncology found that rates of no treatment and early mortality are higher ...
Kerri FitzgeraldMultiple Myeloma | February 27, 2023
The addition of daratumumab to lenalidomide, bortezomib, and dexamethasone therapy improved responses in Black ...